These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11565536)

  • 1. Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia.
    Sabbà C; Gallitelli M; Palasciano G
    N Engl J Med; 2001 Sep; 345(12):926. PubMed ID: 11565536
    [No Abstract]   [Full Text] [Related]  

  • 2. Tranexamic acid in hereditary hemorrhagic telangiectasia.
    Lozano M
    N Engl J Med; 2002 Feb; 346(6):457. PubMed ID: 11832543
    [No Abstract]   [Full Text] [Related]  

  • 3. Intranasal tranexamic acid treatment for severe epistaxis in hereditary hemorrhagic telangiectasia.
    Klepfish A; Berrebi A; Schattner A
    Arch Intern Med; 2001 Mar; 161(5):767. PubMed ID: 11231712
    [No Abstract]   [Full Text] [Related]  

  • 4. Intranasal tranexamic acid for the treatment of hereditary hemorrhagic telangiectasia: a case report and review of treatment options.
    Flanagan BA; Collins C; Parra S
    Cutis; 2012 Feb; 89(2):69-72. PubMed ID: 22474728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) with tranexamic acid].
    Morales-Angulo C; Pérez del Molino A; Zarrabeitia R; Fernández A; Sanz-Rodríguez F; Botella LM
    Acta Otorrinolaringol Esp; 2007 Apr; 58(4):129-32. PubMed ID: 17428407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid - a double-blind placebo-controlled cross-over phase IIIB study.
    Geisthoff UW; Seyfert UT; Kübler M; Bieg B; Plinkert PK; König J
    Thromb Res; 2014 Sep; 134(3):565-71. PubMed ID: 25005464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): regulation of ALK-1/endoglin pathway in endothelial cells.
    Fernandez-L A; Garrido-Martin EM; Sanz-Rodriguez F; Ramirez JR; Morales-Angulo C; Zarrabeitia R; Perez-Molino A; Bernabéu C; Botella LM
    Thromb Haemost; 2007 Feb; 97(2):254-62. PubMed ID: 17264955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial.
    Whitehead KJ; Sautter NB; McWilliams JP; Chakinala MM; Merlo CA; Johnson MH; James M; Everett EM; Clancy MS; Faughnan ME; Oh SP; Olitsky SE; Pyeritz RE; Gossage JR
    JAMA; 2016 Sep; 316(9):943-51. PubMed ID: 27599329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranexamic acid and bevacizumab in hereditary hemorrhagic telangiectasia patients presenting with epistaxis.
    Lacout A; Marcy PY; El Hajjam M; Lacombe P
    Cutis; 2013 Apr; 91(4):173-4. PubMed ID: 23763075
    [No Abstract]   [Full Text] [Related]  

  • 10. [Efficacy of tranexamic acid in a patient with hereditary hemorrhagic telangiectasia and massive epistaxis].
    Pérez del Molino A; Zarrabeitia R; Fernández A; Botella LM
    Med Clin (Barc); 2004 Jun; 123(3):118-9. PubMed ID: 15225479
    [No Abstract]   [Full Text] [Related]  

  • 11. Hereditary haemorrhagic telangiectasia (HHT): negotiating between the Scylla of bleeding and Charybdis of thrombosis.
    Ghosh K; Ghosh K
    Thromb Haemost; 2008 Jul; 100(1):162-4. PubMed ID: 18612556
    [No Abstract]   [Full Text] [Related]  

  • 12. Brief report: treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid.
    Saba HI; Morelli GA; Logrono LA
    N Engl J Med; 1994 Jun; 330(25):1789-90. PubMed ID: 8190155
    [No Abstract]   [Full Text] [Related]  

  • 13. Medical Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Meta-analysis.
    Hsu YP; Hsu CW; Bai CH; Cheng SW; Chen C
    Otolaryngol Head Neck Surg; 2019 Jan; 160(1):22-35. PubMed ID: 30200816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BET 1: Intravenous tranexamic acid in the treatment of acute epistaxis.
    Fox H; Hunter F
    Emerg Med J; 2015 Dec; 32(12):969-70. PubMed ID: 26598634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Best evidence topic reports. BET 3: Topical intranasal tranexamic acid for spontaneous epistaxis.
    Hilton L; Reuben A
    Emerg Med J; 2014 May; 31(5):436-7. PubMed ID: 24846097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a mucosal atomization device for local application of tranexamic acid in epistaxis.
    Heymer J; Schilling T; Räpple D
    Am J Emerg Med; 2018 Dec; 36(12):2327. PubMed ID: 29685357
    [No Abstract]   [Full Text] [Related]  

  • 17. Topical timolol for the treatment of epistaxis in hereditary hemorrhagic telangiectasia.
    Olitsky SE
    Am J Otolaryngol; 2012; 33(3):375-6. PubMed ID: 22079094
    [No Abstract]   [Full Text] [Related]  

  • 18. Subcutaneous Tranexamic Acid at the End of Life in a Patient With Hereditary Hemorrhagic Telangiectasia.
    Arndt G; Wai R; Stiel H
    J Palliat Med; 2024 Jun; 27(6):827-829. PubMed ID: 37768837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease.
    Gaillard S; Dupuis-Girod S; Boutitie F; Rivière S; Morinière S; Hatron PY; Manfredi G; Kaminsky P; Capitaine AL; Roy P; Gueyffier F; Plauchu H;
    J Thromb Haemost; 2014 Sep; 12(9):1494-502. PubMed ID: 25040799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary hemorrhagic telangiectasia/avastin.
    Davidson TM; Olitsky SE; Wei JL
    Laryngoscope; 2010 Feb; 120(2):432-5. PubMed ID: 19998344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.